- Report
- December 2023
- 139 Pages
Global
From €3203EUR$3,560USD£2,740GBP
€4003EUR$4,450USD£3,425GBP
- Report
- November 2023
- 146 Pages
Global
From €3203EUR$3,560USD£2,740GBP
€4003EUR$4,450USD£3,425GBP
- Report
- January 2023
- 132 Pages
Global
From €3203EUR$3,560USD£2,740GBP
€4003EUR$4,450USD£3,425GBP
- Report
- December 2022
- 142 Pages
Global
From €3203EUR$3,560USD£2,740GBP
€4003EUR$4,450USD£3,425GBP
- Report
- August 2022
- 143 Pages
Global
From €3203EUR$3,560USD£2,740GBP
€4003EUR$4,450USD£3,425GBP
- Report
- March 2022
- 124 Pages
Global
From €3203EUR$3,560USD£2,740GBP
€4003EUR$4,450USD£3,425GBP
- Report
- December 2019
- 120 Pages
Global
From €2663EUR$2,960USD£2,279GBP
€3329EUR$3,700USD£2,848GBP
- Report
- January 2024
- 200 Pages
Global
From €3733EUR$4,150USD£3,195GBP
- Report
- October 2023
- 145 Pages
Global
From €2834EUR$3,150USD£2,425GBP
- Report
- November 2023
- 190 Pages
Global
From €3441EUR$3,825USD£2,944GBP
€4048EUR$4,500USD£3,464GBP
- Report
- January 2024
- 150 Pages
Global
From €2924EUR$3,250USD£2,502GBP
€4363EUR$4,850USD£3,733GBP
From €1885EUR$2,095USD£1,613GBP
€3590EUR$3,990USD£3,071GBP
- Report
- June 2025
United Kingdom
From €1885EUR$2,095USD£1,613GBP
€3590EUR$3,990USD£3,071GBP
- Report
- July 2023
- 115 Pages
Global
From €3441EUR$3,825USD£2,944GBP
€4048EUR$4,500USD£3,464GBP
- Report
- January 2024
- 78 Pages
Europe
From €3104EUR$3,450USD£2,656GBP
- Report
- January 2024
- 76 Pages
Asia Pacific
From €3104EUR$3,450USD£2,656GBP
- Report
- January 2024
- 70 Pages
North America
From €3104EUR$3,450USD£2,656GBP
- Report
- January 2024
- 90 Pages
Middle East, Africa
From €3104EUR$3,450USD£2,656GBP
- Report
- January 2024
- 55 Pages
From €3104EUR$3,450USD£2,656GBP
- Report
- September 2022
- 252 Pages
Global
From €4003EUR$4,450USD£3,425GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more